Nanomedicine: Transforming the Management of Ocular Neuroinflammatory and Neurodegenerative Diseases
Nanomedicine is emerging as a groundbreaking strategy for the management of the neuro-visual symptoms of neuroinflammatory and neurodegenerative diseases. This innovative field of study leverages nanoscale materials and technologies to improve drug delivery, enabling targeted treatments to reach the...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Journal of Nanotheranostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2624-845X/6/1/6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849343157660024832 |
|---|---|
| author | Georgia Savvidou Ellas Spyratou Maria-Eleni Zachou Efstathios P. Efstathopoulos |
| author_facet | Georgia Savvidou Ellas Spyratou Maria-Eleni Zachou Efstathios P. Efstathopoulos |
| author_sort | Georgia Savvidou |
| collection | DOAJ |
| description | Nanomedicine is emerging as a groundbreaking strategy for the management of the neuro-visual symptoms of neuroinflammatory and neurodegenerative diseases. This innovative field of study leverages nanoscale materials and technologies to improve drug delivery, enabling targeted treatments to reach the affected ocular tissues. By facilitating the transport of therapeutic agents across the blood–retinal barrier and boosting their bioavailability, nanomedicine holds the potential to significantly mitigate the symptoms of conditions such as Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), etc. This review summarizes the latest developments in nanomedicine applications for the management of these ocular conditions, highlighting their capacity to foster more effective disease diagnosis and treatment. |
| format | Article |
| id | doaj-art-3e0ef8fa47af447f84f7737de7f7c05f |
| institution | Kabale University |
| issn | 2624-845X |
| language | English |
| publishDate | 2025-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Nanotheranostics |
| spelling | doaj-art-3e0ef8fa47af447f84f7737de7f7c05f2025-08-20T03:43:10ZengMDPI AGJournal of Nanotheranostics2624-845X2025-02-0161610.3390/jnt6010006Nanomedicine: Transforming the Management of Ocular Neuroinflammatory and Neurodegenerative DiseasesGeorgia Savvidou0Ellas Spyratou1Maria-Eleni Zachou2Efstathios P. Efstathopoulos3Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece2nd Department of Radiology, Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece2nd Department of Radiology, Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece2nd Department of Radiology, Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, 11527 Athens, GreeceNanomedicine is emerging as a groundbreaking strategy for the management of the neuro-visual symptoms of neuroinflammatory and neurodegenerative diseases. This innovative field of study leverages nanoscale materials and technologies to improve drug delivery, enabling targeted treatments to reach the affected ocular tissues. By facilitating the transport of therapeutic agents across the blood–retinal barrier and boosting their bioavailability, nanomedicine holds the potential to significantly mitigate the symptoms of conditions such as Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), etc. This review summarizes the latest developments in nanomedicine applications for the management of these ocular conditions, highlighting their capacity to foster more effective disease diagnosis and treatment.https://www.mdpi.com/2624-845X/6/1/6neuro-ophthalmologyneurodegenerative diseasesneuroinflammatory diseasesnanotechnologynanomedicine |
| spellingShingle | Georgia Savvidou Ellas Spyratou Maria-Eleni Zachou Efstathios P. Efstathopoulos Nanomedicine: Transforming the Management of Ocular Neuroinflammatory and Neurodegenerative Diseases Journal of Nanotheranostics neuro-ophthalmology neurodegenerative diseases neuroinflammatory diseases nanotechnology nanomedicine |
| title | Nanomedicine: Transforming the Management of Ocular Neuroinflammatory and Neurodegenerative Diseases |
| title_full | Nanomedicine: Transforming the Management of Ocular Neuroinflammatory and Neurodegenerative Diseases |
| title_fullStr | Nanomedicine: Transforming the Management of Ocular Neuroinflammatory and Neurodegenerative Diseases |
| title_full_unstemmed | Nanomedicine: Transforming the Management of Ocular Neuroinflammatory and Neurodegenerative Diseases |
| title_short | Nanomedicine: Transforming the Management of Ocular Neuroinflammatory and Neurodegenerative Diseases |
| title_sort | nanomedicine transforming the management of ocular neuroinflammatory and neurodegenerative diseases |
| topic | neuro-ophthalmology neurodegenerative diseases neuroinflammatory diseases nanotechnology nanomedicine |
| url | https://www.mdpi.com/2624-845X/6/1/6 |
| work_keys_str_mv | AT georgiasavvidou nanomedicinetransformingthemanagementofocularneuroinflammatoryandneurodegenerativediseases AT ellasspyratou nanomedicinetransformingthemanagementofocularneuroinflammatoryandneurodegenerativediseases AT mariaelenizachou nanomedicinetransformingthemanagementofocularneuroinflammatoryandneurodegenerativediseases AT efstathiospefstathopoulos nanomedicinetransformingthemanagementofocularneuroinflammatoryandneurodegenerativediseases |